Syndivia
Next-generation antibody-drug conjugates
Strasbourg, France
< 10 Employees
High Level Pitch
Syndivia is a french biotechnology company that provides best-in-class bioconjugation technologies for the development of Antibody-Drug Conjugates (ADC). Our portfolio includes four unparalleled bioconjugation technologies within the two large domains of bioselective and bioorthogonal chemistries.